Archive

New research may make future design of nanotechnology safer with fewer side effects

Written by | 13 Oct 2023

A new study may offer a strategy that mitigates negative side effects associated with intravenous injection of nanoparticles commonly used in medicine. The study was published today in Nature […]

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants

Written by | 12 Aug 2023

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated the safety and tolerability of a new drug treatment designed as […]

Specialty drugs accounted for most new product launches in the past decade. Why do we know so little about how clinical studies influence their diffusion?

Written by | 20 Jun 2023

Researchers from McGill University and Ontario Tech University published a new Journal of Marketing article that examines the drivers of specialty drug diffusion. The study, forthcoming in the Journal of Marketing, is titled “Scientific Evidence […]

Metformin lowers risk of long COVID

Written by | 10 Jun 2023

Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on […]

Using AI to create better, more potent medicines

Written by | 2 Jun 2023

While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence […]

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Written by | 1 Jun 2023

Research into new drug development is ongoing at a very fast pace globally. In keeping with newer remedies entering the market, there is a need for optimizing existing […]

Artificial intelligence in pharmaceutical sciences revolutionizes drug research and development

Written by | 27 May 2023

Scientists have long been challenged by the complex process of drug discovery and development, with investments that often go unrewarded. However, with the advancement of experimental technology and […]

Tadalafil shows potential as a diabetes treatment

Written by | 17 May 2023

In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug.  Tadalafil […]

Atogepant shows efficacy for prevention of migraine

Written by | 14 May 2023

Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of […]

Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn

Written by | 12 May 2023

Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned. A major investigation into medications used to manage long-term pain […]

Potency drug reduced long-term blood sugar in type 2 diabetes

Written by | 8 May 2023

A small group of patients with type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, a medication used to treat erectile dysfunction. The […]

A 21st-century remedy for missed meds

Written by | 17 Apr 2023

Missing crucial doses of medicines and vaccines could become a thing of the past thanks to Rice University bioengineers’ next-level technology for making time-released drugs. “This is a […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.